LifeMD Earnings Estimate
| LFMD Stock | USD 2.78 0.02 0.71% |
LifeMD Earnings Estimation Breakdown
The calculation of LifeMD's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of LifeMD is estimated to be 0.03625 with the future projection ranging from a low of -0.065 to a high of 0.1375. Please be aware that this consensus of annual earnings estimates for LifeMD Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.07 Lowest | Expected EPS | 0.14 Highest |
LifeMD Earnings Projection Consensus
Suppose the current estimates of LifeMD's value are higher than the current market price of the LifeMD stock. In this case, investors may conclude that LifeMD is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and LifeMD's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 8 | 50.0% | 0.0 | 0.03625 | -0.25 |
LifeMD Earnings History
Earnings estimate consensus by LifeMD Inc analysts from Wall Street is used by the market to judge LifeMD's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only LifeMD's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.LifeMD Quarterly Gross Profit |
|
LifeMD Earnings per Share Projection vs Actual
Actual Earning per Share of LifeMD refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering LifeMD Inc predict the company's earnings will be in the future. The higher the earnings per share of LifeMD, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.LifeMD Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as LifeMD, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of LifeMD should always be considered in relation to other companies to make a more educated investment decision.LifeMD Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact LifeMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-17 | 2025-09-30 | -0.04 | -0.1 | -0.06 | 150 | ||
2025-08-05 | 2025-06-30 | -0.02 | -0.06 | -0.04 | 200 | ||
2025-05-06 | 2025-03-31 | 0.14 | 0.0282 | -0.1118 | 79 | ||
2025-03-10 | 2024-12-31 | 0.14 | 0.21 | 0.07 | 50 | ||
2024-11-07 | 2024-09-30 | -0.12 | -0.14 | -0.02 | 16 | ||
2024-08-07 | 2024-06-30 | -0.12 | -0.19 | -0.07 | 58 | ||
2024-05-08 | 2024-03-31 | -0.15 | -0.19 | -0.04 | 26 | ||
2024-03-11 | 2023-12-31 | -0.14 | -0.12 | 0.02 | 14 | ||
2023-11-08 | 2023-09-30 | -0.15 | -0.2 | -0.05 | 33 | ||
2023-08-09 | 2023-06-30 | -0.1 | -0.23 | -0.13 | 130 | ||
2023-05-12 | 2023-03-31 | -0.16 | -0.15 | 0.01 | 6 | ||
2023-03-22 | 2022-12-31 | -0.18 | -0.4 | -0.22 | 122 | ||
2022-11-10 | 2022-09-30 | -0.28 | -0.26 | 0.02 | 7 | ||
2022-08-11 | 2022-06-30 | -0.35 | -0.45 | -0.1 | 28 | ||
2022-05-13 | 2022-03-31 | -0.36 | -0.46 | -0.1 | 27 | ||
2022-03-07 | 2021-12-31 | -0.42 | -0.62 | -0.2 | 47 | ||
2021-11-10 | 2021-09-30 | -0.62 | -0.54 | 0.08 | 12 | ||
2021-08-12 | 2021-06-30 | -0.53 | -0.64 | -0.11 | 20 | ||
2021-05-13 | 2021-03-31 | -0.67 | -0.47 | 0.2 | 29 | ||
2021-03-29 | 2020-12-31 | -0.24 | -2.56 | -2.32 | 966 | ||
2020-11-16 | 2020-09-30 | -1.03 | -1.03 | 0.0 | 0 |
About LifeMD Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of LifeMD earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current LifeMD estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as LifeMD fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -212.6 M | -202 M | |
| Retained Earnings Total Equity | -171.5 M | -180.1 M | |
| Earnings Yield | (0.09) | (0.11) | |
| Price Earnings Ratio | (9.72) | (10.21) | |
| Price Earnings To Growth Ratio | 0.40 | 0.42 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Will Health Care Equipment & Supplies sector continue expanding? Could LifeMD diversify its offerings? Factors like these will boost the valuation of LifeMD. Expected growth trajectory for LifeMD significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every LifeMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets | Return On Equity |
LifeMD Inc's market price often diverges from its book value, the accounting figure shown on LifeMD's balance sheet. Smart investors calculate LifeMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since LifeMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that LifeMD's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LifeMD represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.